Bone-building drug coming for post-menopause women Health Previous Article AI in healthcare: what are the risks for the NHS? Next Article Drug bypasses suppressive immune cells to unleash immunotherapy Abaloparatide protects against the bone-thinning condition osteoporosis and is approved for NHS use....Read more https://www.bbc.com/news/articles/ckg22prg9y0o Previous Article AI in healthcare: what are the risks for the NHS? Next Article Drug bypasses suppressive immune cells to unleash immunotherapy